Smiths(SMGZY)
Search documents
Smiths(SMGZY) - 2021 Q2 - Earnings Call Transcript
2021-03-26 19:44
Smiths Group plc (OTCPK:SMGKF) Q2 2021 Results Conference Call March 26, 2021 5:00 AM ET Company Participants Andy Reynolds Smith - CEO John Shipsey - CFO Conference Call Participants Andy Wilson - JPMorgan Mark Davies Jones - Stifel Andre Kukhnin - Credit Suisse Robert Davis - Morgan Stanley Christian Hinderaker - Liberum Edward Maravanyika - Citigroup Andy Reynolds Smith Thanks very much indeed, and good morning, everyone. Really appreciate you taking the time to join the call today. Very much hope also t ...
Smiths(SMGZY) - 2021 Q2 - Earnings Call Presentation
2021-03-26 11:37
Financial Performance - Smiths Group's revenue from continuing operations was £1,150 million, a decrease of 7% compared to £1,240 million in H1 2020[10] - Operating profit from continuing operations was £166 million, down 11% from £186 million in H1 2020[10] - The operating profit margin for continuing operations was 144%, a decrease of 60 basis points from 150% in H1 2020[10] - Free cash flow increased significantly to £188 million, a 71% increase from £110 million in H1 2020, with a cash conversion rate of 129%[10] - Smiths Medical, accounted for as discontinued operations, reported revenue of £427 million, a 02% increase, and an operating profit of £89 million, a 2% increase[16] Segment Performance - John Crane's revenue was £410 million, a 10% decrease, with an underlying operating margin of 198%[12, 14] - Smiths Detection's revenue was £350 million, a 6% decrease, with an underlying operating margin of 127%[12, 14] - Flex-Tek's revenue was £238 million, a 1% decrease, with an underlying operating margin of 185%[12, 14] - Smiths Interconnect's revenue was £152 million, an 11% increase, with an underlying operating margin of 121%[12, 14] Strategic Initiatives - The strategic restructuring program is on track, with full £70 million annualised benefits expected from FY2022 onwards[18] - Smiths Group is committed to the separation of Smiths Medical by the end of FY2021[48]
Smiths Group plc (SMGKF) Investor Presentation - Slideshow
2020-09-24 17:12
| --- | --- | |---------------------------------------------------|----------------| | | | | | | | | www.smiths.com | | SMITHS GROUP PLC ANNUAL RESULTS 24 SEPTEMBER 2020 | | | --- | --- | |----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...
Smiths(SMGZY) - 2020 Q4 - Earnings Call Transcript
2020-09-24 16:40
Smiths Group plc (OTCPK:SMGKF) Q4 2020 Earnings Conference Call September 24, 2020 4:00 AM ET Company Participants Andy Reynolds Smith - CEO John Shipsey - CFO Conference Call Participants Mark Davies Jones - Stifel Andy Wilson - JPMorgan Andre Kukhnin - Credit Suisse Robert Davis - Morgan Stanley William Turner - Goldman Sachs Jonathan Hurn - Barclays Andy Reynolds Smith Thanks very much and good morning everyone. Really appreciate you joining us for the Results Call today. I very much hope that you and yo ...
Smiths(SMGZY) - 2020 Q4 - Earnings Call Presentation
2020-09-24 08:53
| --- | --- | |---------------------------------------------------|----------------| | | | | | | | | www.smiths.com | | SMITHS GROUP PLC ANNUAL RESULTS 24 SEPTEMBER 2020 | | | --- | --- | |----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...
Smiths(SMGZY) - 2020 Q2 - Earnings Call Transcript
2020-04-06 18:48
Smiths Group plc (OTCPK:SMGKF) Q2 2020 Earnings Conference Call April 6, 2020 8:30 AM ET Company Participants Andy Reynolds Smith - Chief Executive Officer John Shipsey - Chief Financial Officer Conference Call Participants Andy Wilson - JPMorgan Mark Davies Jones - Stifel Andre Kukhnin - Credit Suisse Ed Maravanyika - Citigroup Will Turner - Goldman Sachs Andy Reynolds Smith Thanks very much, Summer and hey, good morning everyone. I really appreciate you joining the call. I mean, these are very difficult a ...
Smiths(SMGZY) - 2020 Q2 - Earnings Call Presentation
2020-04-06 13:52
Financial Performance - Revenue from continuing operations increased by 8% to £1,240 million, with an underlying growth of 3%[11] - Operating profit from continuing operations rose by 6% to £186 million, with an underlying increase of 1%[11] - Profit before tax increased by 10% to £160 million[11] - Free cash flow increased significantly by 86% to £132 million[11] - Total basic EPS increased by 17% to 469p[11] Divisional Performance - John Crane's revenue increased by 6% to £474 million, driven by original equipment (OE) sales[12] - Smiths Detection's revenue increased by 4% to £378 million, also led by OE sales[12] - Flex-Tek's revenue increased by 3% to £248 million, driven by aerospace[12] - Smiths Interconnect's revenue decreased by 7% to £140 million, due to a market slowdown[12] - Smiths Medical (discontinued operations) reported revenue of £434 million, a 1% increase[14] Balance Sheet and Liquidity - The company has a strong balance sheet with a pension accounting surplus of £486 million[16] - Net debt stands at £13 billion, with a net debt to EBITDA ratio of 18x[16] - The company has liquidity of over £850 million, including approximately £250 million in cash and an undrawn £600 million revolving credit facility[17]